Identification and characterization of a novel cancer/testis antigen gene CAGE.
paper
Cited
Public
Unavailable
- Authors
- Cho, Bomsoo; Lim, Yoon; Lee, Dae-Yeon; Park, Sae-Young; Lee, Hosoon; Kim, Woo Ho; Yang, Hankwang; Bang, Yung-Jue; Jeoung, Doo-Il
- Year
- 2002
- Journal
- Biochemical and biophysical research communications
- PMID
- 11922625
- DOI
- 10.1006/bbrc.2002.6701
We applied serological analysis of cDNA expression library technique to identify cancer-associated genes. We screened cDNA expression libraries of human testis and gastric cancer cell lines with sera of patients with gastric cancers. We identified a gene whose expression is testis-specific among normal tissues. We cloned and characterized this novel gene. It contains D-E-A-D box domain and encodes a putative protein of 630 amino acids with possible helicase activity. It showed wide expression in various cancer tissues and cancer cell lines. The corresponding gene was named cancer-associated gene (CAGE). PCR of human x hamster Radiation Hybrids showed localization of CAGE on the human chromosome Xp22. Transient transfection of CAGE showed predominantly nuclear localization. Both Western blot and plaque assay indicated seroreactivity of CAGE protein. We found that demethylation played a role in the activation of CAGE in some cancer cell lines that do not express it. Cell synchronization experiments showed that the expression of CAGE was related with cell cycle. This suggests that CAGE might play a role in cellular proliferation. Because CAGE is expressed in a variety of cancers but not in normal tissues except testis, this gene can be a target of antitumor immunotherapy.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. | 2010 | 20844286 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Cancer-testis antigen expression in canine melanoma and healthy tissues. | Hindriks E et al. | β | 2025 | β |
| Genetic variants in DDX53 contribute to autism spectrum disorder associated with the Xp22.11 locus. | Scala M et al. | β | 2025 | β |
| Diagnostic value of multi-tumor-associated autoantibody expression in esophageal squamous cell carcinoma and correlation of clinical features. | Zhou S et al. | β | 2024 | β |
| HDAC9 and miR-512 Regulate CAGE-Promoted Anti-Cancer Drug Resistance and Cellular Proliferation. | Yeon M et al. | β | 2024 | β |
| Cancer/testis antigen CAGE mediates osimertinib resistance in non-small cell lung cancer cells and predicts poor prognosis in patients with pulmonary adenocarcinoma. | Yeon M et al. | β | 2023 | β |
| miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53. | Lee KJ et al. | β | 2023 | β |
| Structural insight into crystal structure of helicase domain of DDX53. | Park S et al. | β | 2023 | β |
| The therapeutic potential value of Cancer-testis antigens in immunotherapy of gastric cancer. | Alsadat Mahmoudian R et al. | β | 2023 | β |
| Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy. | Arna AB et al. | β | 2022 | β |
| The CAGE-MiR-181b-5p-S1PR1 Axis Regulates Anticancer Drug Resistance and Autophagy in Gastric Cancer Cells. | Yeon M et al. | β | 2021 | β |
| The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis. | Ali MAM | β | 2021 | β |
| Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach. | Hurtado LΓ³pez AM et al. | β | 2020 | β |
| Emerging relationship between RNA helicases and autophagy. | Zhao MM et al. | β | 2020 | β |
| Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review. | Yang B et al. | β | 2019 | β |
| CAGE-miR-140-5p-Wnt1 Axis Regulates Autophagic Flux, Tumorigenic Potential of Mouse Colon Cancer Cells and Cellular Interactions Mediated by Exosomes. | Yeon M et al. | β | 2019 | β |
| CAGE Binds to Beclin1, Regulates Autophagic Flux and CAGE-Derived Peptide Confers Sensitivity to Anti-cancer Drugs in Non-small Cell Lung Cancer Cells. | Yeon M et al. | β | 2018 | β |
| Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance. | Kwon Y et al. | β | 2018 | β |
| DDX53 Promotes Cancer Stem Cell-Like Properties and Autophagy. | Kim H et al. | β | 2017 | β |
| DDX53 Regulates Cancer Stem Cell-Like Properties by Binding to SOX-2. | Kim Y et al. | β | 2017 | β |
| Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes. | Van Tongelen A et al. | β | 2017 | β |
| Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. | Tang ZM et al. | β | 2017 | β |
| The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3Ξ² and decreasing the expression of cyclinD1. | Kim Y et al. | β | 2017 | β |
| Histone Deacetylase-3/CAGE Axis Targets EGFR Signaling and Regulates the Response to Anti-Cancer Drugs. | Kim H et al. | β | 2016 | β |
| miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2. | Kim Y et al. | β | 2016 | β |
| miR-30a Regulates the Expression of CAGE and p53 and Regulates the Response to Anti-Cancer Drugs. | Park D et al. | β | 2016 | β |
| microRNA-200b as a Switch for Inducible Adult Angiogenesis. | Sinha M et al. | β | 2015 | β |
| miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs. | Kim Y et al. | β | 2013 | β |
| Perturbations of RNA helicases in cancer. | Robert F et al. | β | 2013 | β |
| Selection of anti-cancer-associated gene single-chain variable fragments derived from gastric cancer patients using ribosome display. | Xin L et al. | β | 2013 | β |
| Tumor-associated autoantibody signature for the early detection of gastric cancer. | Zayakin P et al. | β | 2013 | β |
| KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancer. | Song MH et al. | β | 2012 | β |
| X chromosomal mutations and spermatogenic failure. | Stouffs K et al. | β | 2012 | β |
| Aberrant DNA methylation and prostate cancer. | Majumdar S et al. | β | 2011 | β |
| Clinical validation of an autoantibody test for lung cancer. | Boyle P et al. | β | 2011 | β |
| DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer. | Germain DR et al. | β | 2011 | β |
| Insights into cellular factors that regulate HIV-1 replication in human cells. | Lever AM et al. | β | 2011 | β |
| The biology of cancer testis antigens: putative function, regulation and therapeutic potential. | Fratta E et al. | β | 2011 | β |
| A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies. | Liggins AP et al. | β | 2010 | β |
| Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs. | Kim Y et al. | β | 2010 | β |
| Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells. | Atanackovic D et al. | β | 2010 | β |
| Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. | Noor A et al. | β | 2010 | β |
| Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival. | Goonetilleke UR et al. | β | 2010 | β |
| The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner. | Por E et al. | β | 2010 | β |
| CAGE, a cancer/testis antigen, induces c-FLIP(L) and Snail to enhance cell motility and increase resistance to an anti-cancer drug. | Kim Y et al. | β | 2009 | β |
| Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma. | Wang K et al. | β | 2009 | β |
| The cancer/testis antigen CAGE induces MMP-2 through the activation of NF-kappaB and AP-1. | Kim Y et al. | β | 2009 | β |
| A putative DEAD-box RNA-helicase is required for normal zoospore development in the late blight pathogen Phytophthora infestans. | Walker CA et al. | β | 2008 | β |
| Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients. | Dong XY et al. | β | 2008 | β |
| SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification. | Rauch J et al. | β | 2008 | β |
| SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification. | Rauch J et al. | β | 2008 | β |
| Developing effective tumor vaccines: basis, challenges and perspectives. | Xu Q et al. | β | 2007 | β |
| Prostate cancer epigenetics: a review on gene regulation. | Diaw L et al. | β | 2007 | β |
| An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. | Abdul-Rasool S et al. | β | 2006 | β |
| CAGE, a novel cancer/testis antigen gene, promotes cell motility by activation ERK and p38 MAPK and downregulating ROS. | Shim H et al. | β | 2006 | β |
| CAGE displays oncogenic potential and induces cytolytic T lymphocyte activity. | Shim E et al. | β | 2006 | β |
| Cancer/testis antigen cancer-associated gene (CAGE) promotes motility of cancer cells through activation of focal adhesion kinase (FAK). | Shim H et al. | β | 2006 | β |
| Cancer testis antigens--their importance in immunotherapy and in the early detection of cancer. | Suri A | β | 2006 | β |
| Dead-box proteins: a family affair--active and passive players in RNP-remodeling. | Linder P | β | 2006 | β |
| Cancer/testis antigens and gametogenesis: a review and "brain-storming" session. | Kalejs M et al. | β | 2005 | β |
| Cancer/testis antigens, gametogenesis and cancer. | Simpson AJ et al. | β | 2005 | β |
| Differential gene expression in liposarcoma, lipoma, and adipose tissue. | Skubitz KM et al. | β | 2005 | β |
| Epigenetic changes in prostate cancer: implication for diagnosis and treatment. | Li LC et al. | β | 2005 | β |
| Frequent immune responses to a cancer/testis antigen, CAGE, in patients with microsatellite instability-positive endometrial cancer. | Iwata T et al. | β | 2005 | β |
| Identification and analysis of tumour-associated antigens in hepatocellular carcinoma. | Shi YY et al. | β | 2005 | β |
| Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification. | Naka N et al. | β | 2005 | β |
| The cancer/testis antigen CAGE-1 is a component of the acrosome of spermatids and spermatozoa. | Alsheimer M et al. | β | 2005 | β |
| Do human RNA helicases have a role in cancer? | Abdelhaleem M | β | 2004 | β |
| Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. | JΓ€ger D et al. | β | 2004 | β |
| Cancer/testis-associated genes: identification, expression profile, and putative function. | Zendman AJ et al. | β | 2003 | β |
| Novel perspective: focusing on the X chromosome in reproductive cancers. | Liao DJ et al. | β | 2003 | β |
| Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. | Cho B et al. | β | 2003 | β |
| Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. | Scanlan MJ et al. | β | 2002 | β |